These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23054063)

  • 41. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Self-medication of migraine and headache].
    Haag G
    MMW Fortschr Med; 2006 Nov; 148(47):44-5. PubMed ID: 17168188
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study.
    Dowson A; Ball K; Haworth D
    Curr Med Res Opin; 2000; 16(3):190-7. PubMed ID: 11191009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sumatriptan plus naproxen for acute migraine attacks in adults.
    Law S; Derry S; Moore RA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
    Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
    Cady RK; Munjal S; Cady RJ; Manley HR; Brand-Schieber E
    J Headache Pain; 2017 Dec; 18(1):17. PubMed ID: 28176235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial.
    Cady RC; Ryan R; Jhingran P; O'Quinn S; Pait DG
    Arch Intern Med; 1998 May; 158(9):1013-8. PubMed ID: 9588435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
    Goldstein J; Silberstein SD; Saper JR; Ryan RE; Lipton RB
    Headache; 2006 Mar; 46(3):444-53. PubMed ID: 16618262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents.
    Winner P; Rothner AD; Saper J; Nett R; Asgharnejad M; Laurenza A; Austin R; Peykamian M
    Pediatrics; 2000 Nov; 106(5):989-97. PubMed ID: 11061765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study.
    Leinisch E; Evers S; Kaempfe N; Kraemer C; Sostak P; Jürgens T; Straube A; May A
    Pain; 2005 Oct; 117(3):396-400. PubMed ID: 16153780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.